CHENNAI: Swiss-pharma major Novartis AG said early this week that its pediatric malaria treatment, Coartem Baby, received ...

Novartis has received approval for Coartem Baby, the world's first malaria treatment specifically for newborns and young ...

Swissmedic approves Novartis’ Coartem Baby to treat malaria in newborns and young infants: Basel Thursday, July 10, 2025, 11:00 Hrs [IST] Novartis announced Coartem (artemether- ...

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

A new malaria treatment has been approved for newborns and infants under 11lbs, filling a major gap in care for some of the most vulnerable children.

Switzerland’s health regulator Swissmedic granted marketing authorisation on Tuesday for Novartis Riamet Baby, also known as ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants. It ...

Players in the health sector have commended the approval of the first-ever malaria drug for babies weighing less than five ...

A new treatment for malaria in babies and very small children has just been approved; we hear more about the drug expected to save many lives.

Kenya is among eight African countries that participated in clinical trials for a newly approved malaria treatment, ...